| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/08/2008 | US20080108671 Non-systemic control of parasites |
| 05/08/2008 | US20080108670 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 05/08/2008 | US20080108598 Pharmaceutical use of substituted amides |
| 05/08/2008 | US20080108589 Method of treatment with coadministration of aspirin and prasugrel |
| 05/08/2008 | US20080108588 NO-alendronate; NO-pamidronate; NO-clodronate; NO-risedronate; NO-zolendronate; NO-etidronate; NO-ibandronate; NO-tiludronate; NO-neridronate; NO-olpadronate; NO-icadronate; NO-YH529; additional agent such as growth hormones, bone morphogenic proteins enhances bone growth or decreases bone resorption |
| 05/08/2008 | US20080108575 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 05/08/2008 | US20080108559 Compositions and methods for treating diseases through inhibition of dna methylation and histone deacetylase |
| 05/08/2008 | US20080108550 Hdl for the treatment of stroke and other ischemic conditions |
| 05/08/2008 | US20080108135 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 05/08/2008 | US20080107756 Lithium combinations, and uses related thereto |
| 05/08/2008 | US20080107741 Angiogenesis inhibitor particles having a particle size of less than 2000 nm; and associated with the surface thereof at least one surface stabilizer |
| 05/08/2008 | US20080107721 Combination Chemotherapy Comprising A Liposomal Platinum Complex |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107642 Antibodies against gpr64 and uses thereof |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107621 Use Of Il - 6 In Microvascular Complicaitions |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |
| 05/08/2008 | US20080107600 Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same |
| 05/08/2008 | CA2668017A1 Improved conjugates |
| 05/08/2008 | CA2667949A1 Methods for treating depression |
| 05/08/2008 | CA2666750A1 Phenylpropionamide compounds and the use thereof |
| 05/07/2008 | EP1918716A2 Screening for agents modulating TGF-Beta cell signalling |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918000A2 Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| 05/07/2008 | EP1917979A1 Therapeutic agent for atrial fibrillation |
| 05/07/2008 | EP1917969A1 Compositions for preventing depletion of the intestinal flora and organ damage following antibiotic treatment |
| 05/07/2008 | EP1917962A1 Pharmaceutical composition for modified release insulin sensitiser |
| 05/07/2008 | EP1917039A2 Methods and compositions for regenerating articular cartilage |
| 05/07/2008 | EP1917010A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 05/07/2008 | EP1774028A4 Methods and compositions for treating obesity |
| 05/07/2008 | EP1711618A4 Methods for detecting markers associated with endometrial disease or phase |
| 05/07/2008 | EP1651176A4 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 05/07/2008 | EP1509250B1 Methods compositions and articles of manufacture for modulating bone growth |
| 05/07/2008 | EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 05/07/2008 | EP1460969B1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1385531B1 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1365768B1 Use of er-beta selective antagonists as contraceptives |
| 05/07/2008 | EP1356036B1 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/07/2008 | EP1137810B1 Peptide screening assay for the determination of gamma-secretase activity |
| 05/07/2008 | EP1126028B1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | CN101175532A Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
| 05/07/2008 | CN101175531A Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol |
| 05/07/2008 | CN101175495A Combination therapy |
| 05/07/2008 | CN101175480A Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations |
| 05/07/2008 | CN101175474A Methods of reducing microbial contamination |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172159A Acidic biological adhesion heat-variable gelling agent, its preparing method and uses |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172100A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172099A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN100386115C Anti-cancer medicine composition |
| 05/07/2008 | CN100386114C Antidiabetic formulation and method |
| 05/07/2008 | CN100386090C Medical dust cloud agent or granular agent and its use |
| 05/07/2008 | CN100386070C Pharmaceutical formulation comprising melatonin |
| 05/06/2008 | US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368469 Prophylaxis of stroke, cardiovascular death or myocardial infarction by administering an angiotenzin converting enzyme inhibitor: ramipril, ramiprilat or their salts, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin |
| 05/06/2008 | US7368461 Compounds and method for the treatment of overactive bladder |
| 05/06/2008 | US7368438 Non-nucleotide compositions and method for inhibiting platelet aggregation |
| 05/06/2008 | US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 05/06/2008 | US7368423 Composition and method for treating chronic allograft rejection |
| 05/06/2008 | US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines |
| 05/06/2008 | US7368286 Using trangenic cells overexpressing human estrogen receptor gene as model for identifying modulators for treating diabetes, obesity and insulin resistance |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 05/06/2008 | CA2468679C Antibiotic formulation and a method of making this formulation |
| 05/06/2008 | CA2380078C Combination therapy using pentafluorobenzenesulfonamides |
| 05/06/2008 | CA2345675C Two chamber cartridge for atomizers |
| 05/06/2008 | CA2283868C Photosensitizer conjugates for pathogen targeting |
| 05/02/2008 | WO2008052145A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 05/02/2008 | WO2008052143A2 Mixing device and output fluids of same |
| 05/02/2008 | WO2008051759A1 Acetaminophen / ibuprofen combinations |
| 05/02/2008 | WO2008051565A2 A drug-release composition having a therapeutic carrier |
| 05/02/2008 | WO2008050853A1 Therapeutic agents for irritable bowel syndrome |
| 05/02/2008 | WO2008049842A2 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders |
| 05/02/2008 | WO2008049424A2 Pharmaceutical composition for the treatment of allergic diseases |
| 05/02/2008 | WO2008014220A3 Vaccine immunotherapy |
| 05/02/2008 | WO2007131737A3 Medication against breast cancer and related diseases |
| 05/02/2008 | WO2007112386A3 Gdf-9/bmp-15 modulators for the treatment of bone disorders |
| 05/02/2008 | WO2007106264A3 Extended cycle multiphasic oral contraceptive method |
| 05/02/2008 | WO2007061868A3 Treatment of stereotypic, self-injurious and compulsive behaviors using specific serotonin reuptake inhibitors and antagonists of nmda receptors |
| 05/02/2008 | CA2667553A1 Methods and combination therapies for treating alzheimer's disease |
| 05/02/2008 | CA2667543A1 New pharmaceutical combinations for treatment of respiratory and gastrointestinal disorders |
| 05/02/2008 | CA2667176A1 Therapeutic agent for irritable bowel syndrome |
| 05/02/2008 | CA2666582A1 Acetaminophen / ibuprofen combinations |
| 05/01/2008 | US20080103304 Non-nucleotide composition and method for inhibiting platelet aggregation |
| 05/01/2008 | US20080103215 Screening Method |
| 05/01/2008 | US20080103211 Poly(divinylbenzene-styrene)sulfonic acid and levobetaxolol; glaucoma |
| 05/01/2008 | US20080103163 Nociceptine antagonists; hydrochloride salts of N-amidino-2-{[2-(4-chlorobenzoylamino)-6-methylquinazolin-4-yl]amino}cyclohexylamine, 1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one and N-(4-amino-2-methyl-6-quinolyl)-2-[(4-ethylphenoxy)methyl]benzamide |
| 05/01/2008 | US20080103162 Antipruritics |
| 05/01/2008 | US20080103155 Pharmaceutical compositions for the treatment of sexual disorders II |
| 05/01/2008 | US20080103147 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/01/2008 | US20080103146 Highly Selective Norepinephrine Reuptake Inhibitors And Methods Of Using The Same |
| 05/01/2008 | US20080103145 Administering racemic reboxetine component |
| 05/01/2008 | US20080103126 2-[[3-(2-benzo[b]thiophen-5-yl-ethoxy)propyl](methyl)amino]-1-ethanol; antihypoxic agent; synergistic mixture with acetylcholine esterase inhibitor (Tacrine, Donepezil, Rivastigmine); neurodegenerative diseases, ischemic cerebral lesion, cerebral apoplexy, Alzheimer's disease, cognition activator |
| 05/01/2008 | US20080103094 Targeted delivery of drugs for the treatment of viral infections |